Table 2.
The association between overall survival and progression free survival was calculated by Cox regression models.
Factors | P1 value | HR | 95% CI | P2 value | HR | 95% CI |
---|---|---|---|---|---|---|
Gender | 0.352 | 0.682 | 0.305–1.525 | 0.123 | 0.354 | 0.095–1.323 |
Age | 0.231 | 1.495 | 0.775–2.884 | 0.201 | 2.130 | 0.669–6.783 |
Stage | 0.715 | 0.216 | ||||
Genotype | 0.782 | 0.130 | ||||
19deletion | 0.829 | 0.921 | 0.436–1.946 | 0.811 | 0.826 | 0.171–3.963 |
21mutation | 0.655 | 1.225 | 0.504–2.977 | 0.170 | 2.991 | 14.304 |
Smoke | 0.462 | 0.507 | ||||
Smoker | 0.242 | 0.526 | 0.180–1.543 | 0.261 | 0.354 | 0.058–2.164 |
Ex-smoker | 0.312 | 0.511 | 0.139–1.876 | 0.667 | 0.642 | 0.085–4.83 |
Firstline | 0.923 | 0.646 | ||||
Surgery | 0.967 | 0.977 | 0.334–2.856 | 0.963 | 0.949 | 0.105–8.580 |
Complication | 0.112 | 1.706 | 0.882–3.299 | 0.212 | 0.422 | 0.109–1.636 |
P1 value, P value of overall survival; HR, hazard ratio; 95% CI, 95% confidence intervals; P2 value, P value of progression free survival. P values <0.05 were considered statistically significant, with 95% confidence intervals.